Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†.

Speirs, V

Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Sep 2015 - 1890-1897 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1569-8041

10.1093/annonc/mdv242 doi


Aged
Androstadienes--therapeutic use
Antineoplastic Agents--therapeutic use
Aromatase Inhibitors--therapeutic use
Biomarkers, Tumor--genetics
Breast Neoplasms--drug therapy
Disease-Free Survival
Double-Blind Method
Estrogen Receptor beta--biosynthesis
Female
Humans
Middle Aged
Prognosis
Proportional Hazards Models
Retrospective Studies
Tamoxifen--therapeutic use
Treatment Outcome